Voya Financial Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Voya Financial Advisors’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,433	Closed	-$556K	–	421
2021 Q1	$556K	Buy	+12,433	New	+$693K	0.02%	400
2017 Q4	–	Sell	-6,900	Closed	-$363K	–	550
2017 Q3	$363K	Hold	6,900	–	–	0.02%	360
2017 Q2	$357K	Hold	6,900	–	–	0.03%	360
2017 Q1	$266K	Hold	6,900	–	–	0.02%	406
2016 Q4	$335K	Sell	6,900 -530	-7%	-$21K	0.03%	343
2016 Q3	$264K	Buy	+7,430	New	+$232K	0.03%	353
2016 Q2	–	Sell	-7,365	Closed	-$285K	–	412
2016 Q1	$285K	Sell	7,365 -500	-6%	-$20.3K	0.04%	287
2015 Q4	$482K	Buy	7,865 +685	+10%	+$37K	0.07%	199
2015 Q3	$273K	Buy	7,180 +780	+12%	+$40.4K	0.05%	245
2015 Q2	$359K	Hold	6,400	–	–	0.06%	202
2015 Q1	$415K	Buy	+6,400	New	+$434K	0.08%	195

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Voya Financial Advisors's IONS Position: Q2 2021 in Review

Voya Financial Advisors sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 12,433 shares — an estimated $556K sold.

Voya Financial Advisors first reported a position in IONS in Q1 2015 and held it in 11 quarters. The position peaked at $556K in Q1 2021. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

Voya Financial Advisors reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Voya Financial Advisors sold 12,433 Ionis Pharmaceuticals shares in Q2 2021, an estimated $556K.
Voya Financial Advisors first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 11 quarters.
Voya Financial Advisors's Ionis Pharmaceuticals position peaked at $556K in Q1 2021.
337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on Voya Financial Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.